Key Highlights

  • Needham initiated Buy rating on ARM with $200 price target after maintaining Hold for two and a half years
  • ARM introduced its inaugural in-house AGI CPU chip during the “Arm Everywhere” event
  • Meta Platforms became the inaugural customer for ARM’s new silicon technology
  • Jefferies increased price target to $210, projecting $15B in additional revenue by FY2031
  • ARM exceeded EPS projections last quarter ($0.43 vs $0.41) while revenue increased 26.3% year-over-year

Needham initiated a Buy rating on Arm Holdings this Wednesday following a two-and-a-half-year period of maintaining a neutral position, establishing a 12-month price target of $200.


ARM Stock Card
Arm Holdings plc American Depositary Shares, ARM

The investment firm emphasized ARM’s strategic advances in the silicon sector — implementing higher royalty rates, moving into subsystems, and launching proprietary chips. Needham indicated these initiatives are beginning to yield results.

ARM has demonstrated 26.45% revenue expansion throughout the previous twelve months. Nineteen analysts have adjusted their earnings projections upward for the coming period.

A central element of the upgrade rationale involves ARM’s entrance into the silicon market via Meta Platforms. Meta has committed as the inaugural customer for ARM’s debut in-house chip, the AGI CPU, providing the product with a prominent commercial foundation immediately.

The AGI CPU made its debut at ARM’s “Arm Everywhere” event. Jefferies elevated its price target to $210 from $170 following the event, emphasizing the chip’s capacity to produce $15 billion in incremental revenue by fiscal year 2031.

Barclays maintained an Overweight rating while increasing its target to $200 from $165. The financial institution emphasized the energy efficiency of the AGI CPU architecture as a critical benefit for AI workloads.

BofA Securities increased its target to $155 from $140 while maintaining a Neutral rating. Morgan Stanley preserved its Overweight rating with a $135 target, highlighting ARM’s dual-chiplet CPU architecture for AI cloud applications.

Analyst Consensus

The prevailing street consensus indicates a Moderate Buy, with an average price target of $168.17. This assessment derives from 19 Buy ratings, 6 Holds, and 1 Sell.

ARM’s 50-day moving average reaches $120.72, while the 200-day stands at $134.17. The stock trades within a 52-week range of $80.00 to $183.16 and carries a market cap of approximately $165.95 billion.

The company’s P/E ratio reaches 209. InvestingPro identifies the stock as presently overvalued compared to its Fair Value calculation.

During its latest quarter, ARM delivered EPS of $0.43, surpassing estimates of $0.41. Revenue totaled $1.24 billion, advancing 26.3% year-over-year and marginally exceeding the $1.23 billion consensus.

Q4 Guidance

ARM established its Q4 FY2026 guidance at $0.54 to $0.62 EPS. Analysts collectively project full-year EPS of $0.90.

Needham highlighted the emergence of agentic AI and the expanding function of CPUs in AI data centers as extended-term favorable trends for ARM’s market position.

The AGI CPU targets agentic AI workloads, incorporating a many-core, power-efficient architecture. Analysts observe the chip will require software and hardware ecosystem backing to challenge established competitors including Nvidia, Intel, and AMD.

Susquehanna elevated ARM from Neutral to Positive in January with a $150 target. Mizuho reduced its target from $190 to $160 in February while preserving an Outperform rating.

Institutional ownership represents 7.53% of the stock.